Literature DB >> 523355

Candida vaginitis.

R Hurley, J De Louvois.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 523355      PMCID: PMC2425644          DOI: 10.1136/pgmj.55.647.645

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  11 in total

1.  Clinical overview of candidal vaginitis.

Authors:  J D Oriel
Journal:  Proc R Soc Med       Date:  1977

2.  Candidal vaginitis: natural history, predisposing factors and prevention.

Authors:  R S Morton; S Rashid
Journal:  Proc R Soc Med       Date:  1977

3.  Cure and relapse with antifungal therapy.

Authors:  F C Odds
Journal:  Proc R Soc Med       Date:  1977

4.  Immunological aspects of candidal vaginitis.

Authors:  J R Hobbs; D Brigden; F Davidson; M Kahan; J K Oates
Journal:  Proc R Soc Med       Date:  1977

5.  The biology of experimental human cutaneous moniliasis (Candida albicans).

Authors:  H I MAIBACH; A M KLIGMAN
Journal:  Arch Dermatol       Date:  1962-02

6.  Moniliasis of twenty-two years' duration.

Authors:  H A BRUNSTING
Journal:  Arch Derm Syphilol       Date:  1950-05

7.  Inveterate vaginal thrush.

Authors:  R Hurley
Journal:  Practitioner       Date:  1975-12

8.  Criteria for diagnosis of candida vulvovaginitis in pregnant women.

Authors:  C J Carroll; R Hurley; V C Stanley
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-03

9.  Immune abnormalities associated with chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; J M Higgs; R S Wells; M Yamamura; J R Hobbs; P J Holt
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

10.  Morbidity of the lower genital tract during pregnancy.

Authors:  V C Stanley; J B Jones; R Hurley; J E Foulkes; J de Louvois
Journal:  J Clin Pathol       Date:  1975-09       Impact factor: 3.411

View more
  42 in total

1.  Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.

Authors:  F L Wormley; J Chaiban; P L Fidel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Risk factors for candida infection of the genital tract in the tropics.

Authors:  Na Dou; Weiping Li; Enfeng Zhao; Chan Wang; Zhaozhao Xiao; Honghui Zhou
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

3.  Candida Vulvovaginitis in Pregnancy.

Authors:  Jinping Xu; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

Review 4.  Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis.

Authors:  I W Fong
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

5.  Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection.

Authors:  C A Black; F M Eyers; A Russell; M L Dunkley; R L Clancy; K W Beagley
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

6.  Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus.

Authors:  Kristi L Strandberg; Marnie L Peterson; Ying-Chi Lin; Melinda C Pack; David J Chase; Patrick M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

7.  Fluconazole in Candida albicans sepsis during pregnancy: case report and review of the literature.

Authors:  E C Wiesinger; S Mayerhofer; C Wenisch; S Breyer; W Graninger
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

8.  Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 10.  The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases.

Authors:  L Latéy Bradford; Jacques Ravel
Journal:  Virulence       Date:  2016-09-22       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.